Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 9/20 | 0.63 |
| ▸ | GAA | P10253 | 8/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.63 |
| ▸ | MEN1 | O00255 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 6/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | NPC1 | O15118 | 5/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | DDX3X | O00571 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21626722 | 0.86 | GAA (0.59) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL11388174 | 0.85 | NOX1 (0.91) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL11388177 | 0.85 | NOX1 (0.91) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL13890516 | 0.83 | MAPT (0.63) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL13875561 | 0.82 | NOX1 (0.61) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL22874080 | 0.81 | NOX1 (1.00) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL42160 | 0.81 | NOX1 (1.00) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL42159 | 0.81 | NOX1 (1.00) | NOX1MAPTGAAKMT2AMEN1 | |
| SCHEMBL13187300 | 0.80 | NPC1 (0.70) | MAPTGAAKMT2AMEN1ALDH1A1 | |
| SCHEMBL14831647 | 0.80 | GAA (0.62) | NOX1MAPTGAAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | BAYER AG (DE) | 2026-01-08 | — | — | US | disclosed |
| CN-119698496-A | Electrochemical synthesis of pyrazolines and pyrazoles | 拜耳公司 | 2025-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | CYP2E1, CYP2F1, CYP4F2 | NOX1 280/4885MAPT 4836/4885GAA 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.